Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin Induced Cardiotoxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Not applicableActive Not RecruitingNCT05078190
What this trial is testing

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

Who this might be right for
Breast CancerCardiotoxicityDrug-Related Side Effects and Adverse Reactions+1 more
Abramson Cancer Center at Penn Medicine 200
Testing effectiveness (Phase 2)Study completedNCT06155331
What this trial is testing

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer Stage 2 and 3
Tanta University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06427226
What this trial is testing

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast Cancer
Tanta University 46
Testing effectiveness (Phase 2)Study completedNCT06703593
What this trial is testing

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer Female
British University In Egypt 80
Not applicableUnknownNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Not applicableStudy completedNCT02423356
What this trial is testing

Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

Who this might be right for
Breast NeoplasmsLymphomaSarcoma
Daniel Rushing 12
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07436663
What this trial is testing

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

Who this might be right for
Breast Cancer
Tanta University 150
Not applicableUnknownNCT05146843
What this trial is testing

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

Who this might be right for
Breast Neoplasms
D'Or Institute for Research and Education 44
Testing effectiveness (Phase 2)Study completedNCT01095926
What this trial is testing

Pharmacokinetic Study of Doxorubicin in Children With Cancer

Who this might be right for
Wilms TumorNeuroblastomaSoft Tissue Sarcoma+1 more
University Hospital Muenster 101
Testing effectiveness (Phase 2)Study completedNCT00377559
What this trial is testing

Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Catharina Ziekenhuis Eindhoven 70
Testing effectiveness (Phase 2)Study completedNCT07668076
What this trial is testing

The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Damanhour University 44
Not applicableStudy completedNCT05959889
What this trial is testing

Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer

Who this might be right for
Breast CancerDoxorubicin Induced Cardiotoxicity
Damanhour University 50
Testing effectiveness (Phase 2)Ended earlyNCT02472353
What this trial is testing

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer

Who this might be right for
Breast CancerBreast Tumors
Avera McKennan Hospital & University Health Center 30
Not applicableStudy completedNCT04568161
What this trial is testing

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Who this might be right for
CardiotoxicityCardiovascular DiseaseNeurovascular Disorder+2 more
University of Sao Paulo General Hospital 15
Large-scale testing (Phase 3)Study completedNCT00854568
What this trial is testing

Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Who this might be right for
Lymphoma
Fudan University 398